ATCC® 2601™ | Saccharomyces kudriavzevii

Overview

Annotations

Related Genomes

Quality Control

Assembly Summary
Date Published	December 15, 2021
Length	22,959,926 nt
Sequencing Technology	Illumina + Oxford Nanopore Hybrid Assembly
Number of Contigs	37 (0 Circularized)
N50	913,476 nt
%GC	39.07%

Organism Summary
Name	ATCC® 2601™
Tags
Biosafety Level	1
Type Strain

Annotations Summary
Number of BUSCO Annotations	736

Input Reads Summary
Oxford Nanopore Read Count	508,049
Oxford Nanopore Median Q Score	24
Illumina Read Count	16,133,968
Illumina Mean Coverage Depth	91.826×
Illumina Median Q Score	34

Sequencing Quality Control

Quality control statistics on Illumina sequencing data.

4 out of 4 passed

PassedNumber of trimmed reads16,133,968

PassedMedian Q score, all bases34

PassedPercent of median Q scores per cycle greater than 251%

PassedAmbiguous content (% N bases)0%

BUSCO Quality Control

Metrics assessing the assembly quality (from BUSCO).

1 out of 2 passed, 1 requires inspection

PassedEstimated genome completeness91.56%

CautionAverage depth of coverage91.826×

Notes

The strain was originally classified as Saccharomyces cerevisiae based on traditional taxonomic characterizations, but a multigene sequence analysis identified it as Saccharomyces kudriavzevii a close relative of Saccharomyces cerevisiae [1]. Recent next-generation sequencing has shown that this strain could be a hybrid of Saccharomyces kudriavzevii and Saccharomyces cerevisiae. This taxonomic update to the strain will not affect its application in antifungal drug testing assays and many other usages. [1] Suh SO, et al. Update of USP drug testing reference strain ATCC® 2601™. Pharma. Microbiol. Forum Newslett. 19: 4-11, 2013.

Saccharomyces kudriavzevii (ATCC® 2601™)